deltatrials
Completed NCT00001313

Evaluation of Patients With Known or Suspected Heart Disease

Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Coronary Disease Diabetes and Heart Failure Dilated Cardiomyopathy Heart Failure Peripheral Artery Disease Pulmonary Hypertension Renal Artery Stenosis
Updated 6 times since 2017 Last updated: Jun 30, 2017 Started: May 10, 1992 Completion: Jan 6, 2009

Listed as NCT00001313, this observational or N/A phase trial focuses on Coronary Disease and Diabetes and Heart Failure and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 6 times since 1992, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

  5. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

▶ Show 1 earlier version

  1. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

May 1992

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Bethesda, United States